199 related articles for article (PubMed ID: 11465967)
1. Antihypertensive therapy and the risk of malignancies.
Grossman E; Messerli FH; Goldbourt U
Eur Heart J; 2001 Aug; 22(15):1343-52. PubMed ID: 11465967
[TBL] [Abstract][Full Text] [Related]
2. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
3. [Antihypertensive drugs and malignant neoplasia].
Preobrazhenskiĭ DV; Sidorenko BA; Stetsenko TM; Kiktev VG
Kardiologiia; 2002; 42(5):62-7. PubMed ID: 12494152
[TBL] [Abstract][Full Text] [Related]
4. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenicity of cardiovascular drugs.
Grossman E; Messerli FH; Goldbourt U
Curr Hypertens Rep; 1999 Jun; 1(3):212-8. PubMed ID: 10981068
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of antihypertensive medication use and breast cancer among Danish women.
Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S
Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
[TBL] [Abstract][Full Text] [Related]
8. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL
J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of antihypertensive drugs and risk of cancer.
Assimes TL; Elstein E; Langleben A; Suissa S
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
[TBL] [Abstract][Full Text] [Related]
11. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials.
Coleman CI; Baker WL; Kluger J; White CM
J Hypertens; 2008 Apr; 26(4):622-9. PubMed ID: 18327066
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
[TBL] [Abstract][Full Text] [Related]
16. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
Krum H; Haas SJ; Eichhorn E; Ghali J; Gilbert E; Lechat P; Packer M; Roecker E; Verkenne P; Wedel H; Wikstrand J
Eur Heart J; 2005 Oct; 26(20):2154-8. PubMed ID: 16014644
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
Bangalore S; Parkar S; Grossman E; Messerli FH
Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
[TBL] [Abstract][Full Text] [Related]
18. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP).
Eland IA; Sundström A; Velo GP; Andersen M; Sturkenboom MC; Langman MJ; Stricker BH; Wiholm B;
Scand J Gastroenterol; 2006 Dec; 41(12):1484-90. PubMed ID: 17101581
[TBL] [Abstract][Full Text] [Related]
20. Which, if any, antihypertensive agents cause cancer?
Singh A; Bangalore S
Curr Opin Cardiol; 2012 Jul; 27(4):374-80. PubMed ID: 22565138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
